Hale Advisors, the digital governance experts for life sciences, is delighted to announce that Rebecca Zobbe has joined the company as Head of Business Development. 

In this role, she will nurture the company’s ongoing growth and help expand its services to meet surging market demand for digital governance solutions.

Rebecca will be responsible for consulting with marketing and promotional review clients on the central challenges of their omnichannel journeys and tailoring Hale Advisors’ digital governance solutions accordingly so that pharmaceutical, biotechnology, and medical device companies of all sizes can confidently develop compliant and innovative omnichannel marketing.

Chief Executive Officer Zoë Dunn said, “Rebecca is a respected industry thought leader. I’m thrilled to welcome her to this important role as we scale solutions that create readiness for omnichannel marketing and modular content. Rebecca’s deep knowledge of the promotional review process, and her ability to spot and respond to emerging innovations, will be of great benefit to our clients and the industry at large.”

An accomplished marketing operations leader, Rebecca brings exceptional life sciences knowledge drawn from 10 years’ experience directing marketing operations strategy and infrastructure at large pharmaceutical and biotechnology companies. In addition, she has over 10 years’ experience providing professional services and thought leadership in support of content development and related medical, legal, and regulatory review processes and technology platforms.

“In Hale Advisors, I’ve found an extraordinary team committed to a vision where creativity and innovation can thrive—not despite regulatory constraints, but because of them,” said Rebecca. “Pharmas are discovering that successfully executing omnichannel content requires a foundation of solid digital governance along with change support. I’m so excited to help architect these solutions for their teams.”